Hormone and fertility drug use and the risk of neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group

American Journal of Epidemiology

Volumn 150, Issue 9, 1999, Pages 930-938

  Olshan, Andrew F ^a,d   Smith, Joanna ^a   Cook, Michael N ^a   Grufferman, Seymour ^b   Pollock, Brad H ^c   Stram, Daniel O ^d   Seeger, Robert C ^e   Look, A Thomas ^f   Cohn, Susan L ^g,h   Castleberry, Robert P ⁱ   Bondy, Melissa L ^j  

^a IL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ University of Alabama at Birmingham   (United States)

^j UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

8 fertility agents; Child; Hormones; Neuroblastoma; Pregnancy; Sex

Indexed keywords

CLOMIFENE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ARTICLE; CANCER RISK; CHILD; FEMALE; HUMAN; INFANT; INFERTILITY THERAPY; MALE; NEUROBLASTOMA; ORAL CONTRACEPTION; PRENATAL DRUG EXPOSURE; PROGENY; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 0033230653     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010101     Document Type: Article

References (23)

1. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. Philadelphia, PA: JB Lippincott Company, 1993:739-68.
2. Spitz MR, Johnson CC. Neuroblastoma and paternal occupation: a case-control analysis. Am J Epidemiol 1985;121:924-9.
3. Bunin GR, Ward E, Kramer S, et al. Neuroblastoma and parental occupation. Am J Epidemiol 1990;131:776-80.
4. Kramer S, Ward E, Meadows AT, et al. Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst 1987;78:797-804.
5. Schwartzbaum JA. Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol 1992;135:1358-67.
6. Michalek AM, Buck GM, Nasca PC, et al. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 1996;143:996-1001.
7. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-81.
8. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Supplement 7. Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. Lyon, France: IARC, 1987.
9. Robison LL, Buckley JD, Bunin G. Assessment of environmental and genetic factors in the etiology of childhood cancers: the Childrens Cancer Group epidemiology program. Environ Health Perspect 1995;103(suppl 6):111-16.
10. Ross JA, Severson RK, Pollock BH, et al. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 1996;77: 201-7.
11. Robison LL, Daigle A. Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol 1984; 120:164-6.
12. Breslow NE, Day NE, eds. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publication no. 32).
13. Brodeur GM, Maris JM, Yamashiro DJ, et al. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 1997;19:93-101.
14. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage. Science 1984;224:1121-4.
15. Shapiro DN, Valentine MB, Rowe ST, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol 1993;142: 1339-46.
16. Mandel M, Toren A, Rechavi G, et al. Hormonal treatment in pregnancy: a possible risk factor for neuroblastoma. Med Pediatr Oncol 1994;23:133-5.
17. White L, Giri N, Vowels MR, et al. Neuroectodermal tumours in children born after assisted conception. (Letter). Lancet 1990;336:1577.
18. Kobayashi N, Matsui I, Tanimura M, et al. Childhood neuroectodermal tumours and malignant lymphoma after maternal ovulation induction. (Letter). Lancet 1991;338:955.
19. Werler MM, Pober BR, Nelson K, et al. Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol 1989;129:415-21.
20. Swan SH, Shaw GM. Reporting accuracy among mothers of malformed and nonmalformed infants. (Letter). Am J Epidemiol 1990;131:935-6.
21. Werler MM, Pober BR. Reporting accuracy among mothers of malformed and nonmalformed infants. The Authors Reply. (Letter). Am J Epidemiol 1990;131:937-8.
22. McLachlan JA, Newbold RR, Li S, et al. Are estrogens carcinogenic during the development of the testes? APMIS 1998;106:240-4.
23. Sharpe RM, Skakkebaek N. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392-5.